การดูแลผู้สูงอายุโรคปอดอักเสบในชุมชนที่ได้รับการบำบัดด้วยออกซิเจนอัตราการไหลสูง :  หลักการพยาบาลและการนำไปใช้

Sasikan  Pongtriang; Jutatip  Changto; Supattra  Chaiponbal; Teepatad Chintapanyakun

Authors

Sasikan Pongtriang Department of Nursing Service, Faculty of Medicine, Ramathibodi Hospital, Mahidol University
Jutatip Changto Department of Nursing Service, Faculty of Medicine, Ramathibodi Hospital, Mahidol University
Supattra Chaiponbal Department of Nursing Service, Faculty of Medicine, Ramathibodi Hospital, Mahidol University
Teepatad Chintapanyakun Department of Nursing Service, Faculty of Medicine, Ramathibodi Hospital, Mahidol University

Keywords:

community-acquired pneumonia, high-flow nasal cannula, quality nursing care

Abstract

Community-acquired pneumonia (CAP) is one of the most significant infectious diseases and a major cause of morbidity and mortality worldwide. The causes of CAP include typical bacterial pathogens such as Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis. The assessment of pneumonia severity can be done using CURB-65, which consists of confusion, uremia, respiratory rate, blood pressure, and age over 65 years in admitted patients. The clinical presentation of CAP is shown by fever and productive cough. In severe cases, pneumonia is indicated by respiratory distress and sepsis. High-flow nasal cannula (HFNC) is an alternative treatment for patients with CAP who have acute hypoxemic respiratory failure. It delivers a flow rate of up to 60 L/min, with humidification and heating, and a constant fraction of inspired oxygen (FiO₂) via nasal cannula. Therefore, nurses should have knowledge about the definition and types of pneumonia, the causes and risk factors of CAP, assessment of CAP, treatment guidelines, and the concepts and principles of using HFNC for patients with CAP, in order to enhance the quality of nursing care for patients with CAP admitted to the hospital, with efficiency and effectiveness.

Downloads

Download data is not yet available.

References

Carlos, P., Gomes, R., Coelho, J., Chaves, C., Tuna, C., & Louro, M. (2023). CURB-65 and long-term mortality of community-acquired pneumonia: A retrospective study on hospitalized patients. Cureus, 15(3), e36052. https://doi.org/10.7759/cureus.36052

Chintapanyakun, T. & Tamsat, A. (2021). High flow nasal cannula oxygen for adults and elders: From evidence to clinical nursing practice. Journal of The Police Nurses, 13(1), 253–264.

Crotty, K. M., & Yeligar, S. M. (2022). Hyaladherins may be implicated in alcohol-induced susceptibility to bacterial pneumonia. Frontiers in Immunology, 13, 865522. https://doi.org/10.3389/fimmu.2022.865522

Davis, D., Thadhani, J., Choudhary, V., Nausheem, R., Vallejo-Zambrano, C. R., Mohammad Arifuddin, B., . . . Nagarajan, L. (2023). Advancements in the management of severe community-acquired pneumonia: A comprehensive narrative review. Cureus, 15(10), e46893.

Fine, M. J., Auble, T. E., Yealy, D. M., Hanusa, B. H., Weissfeld, L. A., Singer, D. E., . . . Kapoor, W. N. (1997). A prediction rule to identify low-risk patients with community-acquired pneumonia. The New England Journal of Medicine, 336(4), 243–250. https://doi.org/10.1056/NEJM199701233360402

Guglielmo, R. D., Hotz, J. C., Ross, P. A., Deakers, T. W., Diep, J. E. L., Newth, C. J. L., . . . Khemani, R. G. (2022). High-flow nasal cannula reduces effort of breathing but not consistently via positive end-expiratory pressure. Chest, 162(4), 861–871. https://doi.org/10.1016/j.chest.2022.03.008

Jiang, C., Chen, Q., & Xie, M. (2020). Smoking increases the risk of infectious diseases: A narrative review. Tobacco Induced Diseases, 18, 60. https://doi.org/10.18332/tid/123845

Jones, B. E., Herman, D. D., Dela Cruz, C. S., Waterer, G. W., Metlay, J. P., Ruminjo, J. K., . . . Thomson, C. C. (2020). Summary for clinicians: Clinical practice guideline for the diagnosis and treatment of community-acquired pneumonia. Annals of the American Thoracic Society, 17(2), 133–138.

Marrie, T. J., Beecroft, M., Herman-Gnjidic, Z., & Poulin-Costello, M. (2004). Symptom resolution in patients with mycoplasma pneumoniae pneumonia. Canadian Respiratory Journal, 11(8), 573–577. https://doi.org/10.1155/2004/659187

Martin-Loeches, I., Torres, A., Nagavci, B., Aliberti, S., Antonelli, M., Bassetti, M., . . . Wunderink, R. (2023). ERS/ESICM/ ESCMID/ALAT guidelines for the management of severe community-acquired pneumonia. Intensive Care Medicine, 49(6), 615–632.

Mauri, T., Wang, Y. M., Dalla Corte, F., Corcione, N., Spinelli, E., & Pesenti, A. (2019). Nasal high flow: Physiology, efficacy and safety in the acute care setting: A narrative review. Open Access Emergency Medicine, 11, 109-120. https://doi.org/10.2147/OAEM.S180197

Metlay, J. P., Waterer, G. W., Long, A. C., Anzueto, A., Brozek, J., Crothers, K., . . . Whitney, C. G. (2019). Diagnosis and treatment of adults with community-acquired pneumonia. American Journal of Respiratory and Critical Care Medicine, 200(7), e45–e67.

Monro-Somerville, T., Sim, M., Ruddy, J., Vilas, M., & Gillies, M. A. (2017). The effect of high-flow nasal cannula oxygen therapy on mortality and intubation rate in acute respiratory failure: A systematic review and meta-analysis. Critical Care Medicine, 45(4), e449- e456. https://doi.org/10.1097/CCM.0000000000002091

Musher, D. M., & Thorner, A. R. (2014). Community-acquired pneumonia. The New England Journal of Medicine, 371(17), 1619–1628.

Niederman, M. S., & Torres, A. (2022). Severe community-acquired pneumonia. European Respiratory Review, 31(166), 220123. https://doi.org/10.1183/16000617.0123-2022

Nishimura, M. (2015). High-flow nasal cannula oxygen therapy in adults. Journal of Intensive Care, 3(1), 15. https://doi.org/10.1186/s40560-015-0084-5

Nishimura, M. (2016). High-flow nasal cannula oxygen therapy in adults: Physiological benefits, indication, clinical benefits, and adverse effects. Respiratory Care, 61(4), 529-541. https://doi.org/10.4187/respcare.04577

Pates, K. M., Periselneris, J. N., & Brown, J. S. (2023). Pneumonia. Medicine, 51(11), 763-767.

Pornsirirat, T., & Tongyoo, S. (2020). Nursing care for adult patients with acute hypoxic respiratory failure receiving high flow nasal cannula. Siriraj Medical Bulletin, 13(1), 60-68.

Roca, O., Hernández, G., Díaz-Lobato, S., Carratalá, J. M., Gutiérrez, R. M., Masclans, J. R., . . . Spanish Multidisciplinary Group of High Flow Supportive Therapy in Adults (HiSpaFlow). (2016). Current evidence for the effectiveness of heated and humidified high flow nasal cannula supportive therapy in adult patients with respiratory failure. Critical Care, 20(1), 109. https://doi.org/10.1186/s13054-016-1263-z

Tamsat, A. (2022). Assessment of severity of symptoms among patients with pneumonia in medical ward. Journal of Royal Thai Army Nurses, 23(1), 483-489.

Tucker, E., O'Sullivan, M., & Waddell, L. (2024). Controversies in the management of community-acquired pneumonia in adults. Australian Prescriber, 47(3), 80-84. https://doi.org/10.18773/austprescr.2024.024

Vaughn, V. M., Dickson, R. P., Horowitz, J. K., & Flanders, S. A. (2024). Community-acquired pneumonia: A review. JAMA, 332(15), 1282–1295.

Zhou, X., Liu, J., Pan, J., Xu, Z., & Xu, J. (2022). The ROX index as a predictor of high-flow nasal cannula outcome in pneumonia patients with acute hypoxemic respiratory failure: A systematic review and meta-analysis. BMC Pulmonary Medicine, 22(1), 121. https://doi.org/10.1186/s12890-022-01914-2